Changes in OCT-Angiography of type 2 CNV in neovascular AMD during anti-VEGF treatment.

被引：0
|
作者：
Faatz, Henrik [1 ]
Farecki, Marie-Louise [1 ]
Heimes, Britta [1 ]
Kai, Rothaus [1 ]
Lommatzsch, Albrecht [1 ]
Pauleikhoff, Daniel [1 ]
机构：
[1] St Franziskus Hosp Munster, Munster, Nrw, Germany
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2017年 / 58卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
403
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Long-Term Impact of Diabetic Retinopathy on Response to Anti-VEGF Treatment in Neovascular AMD
    Boscia, Giacomo
    Bacherini, Daniela
    Vujosevic, Stela
    Grassi, Maria Oliva
    Borrelli, Enrico
    Giancipoli, Ermete
    Landini, Luca
    Pignataro, Mariagrazia
    Alessio, Giovanni
    Boscia, Francesco
    Viggiano, Pasquale
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (10)
  • [32] Current and upcoming anti-VEGF therapies and dosing strategies for the treatment of neovascular AMD: a comparative review
    Khanna, Saira
    Komati, Rahul
    Eichenbaum, David A.
    Hariprasad, Ishani
    Ciulla, Thomas A.
    Hariprasad, Seenu M.
    BMJ OPEN OPHTHALMOLOGY, 2019, 4 (01):
  • [33] Defining the risk of adverse cardiovascular events for patients undergoing anti-VEGF treatment for neovascular AMD
    Chong, David Donghan
    Maatouk, Christopher M.
    Singh, Rishi
    Talcott, Katherine
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [34] Real-World Treatment Patterns in a Population With Neovascular AMD Treated With Anti-VEGF Agents
    Urbano, Catherine A.
    Maatouk, Christopher
    Greenlee, Tyler
    Chen, Andrew
    Conti, Thais F.
    Briskin, Isaac
    Singh, Rishi P.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2021, 52 (04): : 190 - 198
  • [35] AUDIT ON ANTI-VEGF TREATMENT FOR NEOVASCULAR AMD AT THE ROYAL VICTORIAN EYE AND EAR HOSPITAL (RVEEH)
    Abedi, Farshad
    Guymer, Robyn
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2011, 39 : 73 - 73
  • [36] Treatment Burden in Neovascular AMD: Visual Acuity Outcomes are Associated With Anti-VEGF Injection Frequency
    Hussain, Rehan M.
    Hariprasad, Seenu M.
    Ciulla, Thomas A.
    OPHTHALMIC SURGERY LASERS & IMAGING RETINA, 2017, 48 (10): : 780 - 784
  • [37] The SWIM 2 (Switching from Intermittent Anti-VEGF to Monthly Therapy in Neovascular AMD) Study
    Kashiwa, Kellen
    Bennett, Michael
    Hooten, Claudia
    Demaine, Kent
    Milroy, Christopher
    Stark, Bryn
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [38] Anti-VEGF treatment for subfoveal idiopathic (type II) choroidal neovascular membranes
    Hsing, Y. Eve
    Lee, Lawrence R.
    CLINICAL AND EXPERIMENTAL OPTOMETRY, 2012, 95 (05) : 544 - 547
  • [39] VARIANTS IN THE APOE GENE ARE ASSOCIATED WITH IMPROVED TREATMENT OUTCOME FOLLOWING ANTI-VEGF THERAPY FOR NEOVASCULAR AMD
    Wickremasinghe, Sanj
    Lim, Jonathan
    Xie, Jing
    Chauhan, Devinder
    Robman, Luba
    Richardson, Andrea
    Hageman, Gregory
    Baird, Paul
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2010, 38 : 11 - 11
  • [40] Epidemiological and Clinical Baseline Characteristics as Predictive Biomarkers of Response to Anti-VEGF Treatment in Patients with Neovascular AMD
    Tsilimbaris, Miltiadis K.
    Lopez-Galvez, Maria I.
    Gallego-Pinazo, Roberto
    Margaron, Philippe
    Lambrou, George N.
    JOURNAL OF OPHTHALMOLOGY, 2016, 2016
12345